Literature DB >> 7743353

Comparison between lung and liver lipid peroxidation and mortality after zymosan peritonitis in the rat.

R Demling1, U Nayak, K Ikegami, C LaLonde.   

Abstract

We compared the mortality rate and the lung and liver histologic injury with the degree of tissue lipid peroxidation after zymosan-induced peritonitis. Male Wistar rats were given .75 or 1 mg/g of zymosan intraperitoneally and monitored for 24 h. Tissue lipid peroxides were measured as conjugated dienes and malondialdehyde (MDA) as were the antioxidants, ascorbic acid and catalase. Mortality rates for the .75 and 1 mg/g groups were 15 and 50%, respectively. In lung, the degree of increase in conjugated dienes and MDA was significantly greater in nonsurvivors than survivors. Ascorbic acid and catalase levels were also significantly decreased to a greater degree in the sicker animals with ascorbic acid decreased to a greater degree in the higher dose and sicker animals. The level of MDA corresponded with the degree of histologic change. Catalase decreased to a greater degree in liver than lung. We conclude that the degree of lung and liver lipid peroxidation correlates with the degree of inflammation induced tissue injury and mortality.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7743353     DOI: 10.1097/00024382-199409000-00011

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

1.  Interleukin-10 gene transfer: prevention of multiple organ injury in a murine cecal ligation and puncture model of sepsis.

Authors:  Burhan Kabay; Cetin Kocaefe; Atac Baykal; Hilmi Ozden; Cengiz Baycu; Zafer Oner; Meral Ozgüç; Iskender Sayek
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

2.  Beneficial effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in zymosan-induced shock.

Authors:  S Cuzzocrea; G Costantino; E Mazzon; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock.

Authors:  Stefania Marzocco; Rosanna Di Paola; Emanuela Mazzon; Tiziana Genovese; Domenico Britti; Aldo Pinto; Giuseppina Autore; Salvatore Cuzzocrea
Journal:  Intensive Care Med       Date:  2005-03-15       Impact factor: 17.440

4.  Role of 5-lipoxygenase in the multiple organ failure induced by zymosan.

Authors:  Salvatore Cuzzocrea; Antonietta Rossi; Ivana Serraino; Rosanna Di Paola; Laura Dugo; Tiziana Genovese; Domenico Britti; Giuseppe Sciarra; Angelina De Sarro; Achille P Caputi; Lidia Sautebin
Journal:  Intensive Care Med       Date:  2004-07-06       Impact factor: 17.440

5.  Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study.

Authors:  Maria Galuppo; Rosanna Di Paola; Emanuela Mazzon; Tiziana Genovese; Concetta Crisafulli; Irene Paterniti; Elisabetta Cuzzocrea; Placido Bramanti; Amar Kapoor; Christoph Thiemermann; Salvatore Cuzzocrea
Journal:  J Inflamm (Lond)       Date:  2010-02-18       Impact factor: 4.981

6.  Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway.

Authors:  Seyhan Sahan-Firat; Meryem Temiz-Resitoglu; Demet Sinem Guden; Sefika Pinar Kucukkavruk; Bahar Tunctan; Ayse Nihal Sari; Zumrut Kocak; Kafait U Malik
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

7.  Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome.

Authors:  Francesco Imperatore; Salvatore Cuzzocrea; Carlo Luongo; Giovanni Liguori; Antonella Scafuro; Antonella De Angelis; Francesco Rossi; Achille P Caputi; Amelia Filippelli
Journal:  Intensive Care Med       Date:  2004-02-12       Impact factor: 17.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.